{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-252624","form_type":"8-K","ticker":"ACHV","cik":"0000949858","company_name":"ACHIEVE LIFE SCIENCES, INC.","filed_at":"2026-06-02T12:51:39+00:00","discovered_at":"2026-06-02T12:55:00.355507+00:00","generated_at":"2026-06-02T12:55:17.361732+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Achieve Life Sciences appoints Jeff Farrow and Dr. Reid Waldman to Board","bullets":["Jeff Farrow appointed to Audit Committee as Chair and Nominating & Governance Committee as member.","Dr. Reid Waldman appointed to Compensation Committee as Chair and Commercial Committee as member.","Each new director receives pro-rated $40,000 annual retainer for FY 2026 plus committee cash compensation.","Each receives a stock option for 47,250 shares vesting monthly over three years."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-252624","json":"https://secwatch.observer/filing/0001193125-26-252624.json","markdown":"https://secwatch.observer/filing/0001193125-26-252624.md","text":"https://secwatch.observer/filing/0001193125-26-252624.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/949858/000119312526252624/0001193125-26-252624-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/949858/000119312526252624/achv-20260529.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T12:55:17.361732+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4e7df7e90f","claim":"Reid Waldman was appointed as Director at ACHIEVE LIFE SCIENCES, INC..","evidence_excerpt":"the Board of Directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”) appointed Jeff Farrow and Reid Waldman, M.D. (together, the “Incoming Directors”), as directors, effective as of such date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526252624/0001193125-26-252624-index.htm","confidence":0.95},{"claim_id":"bcc2c977c8","claim":"Jeff Farrow was appointed as Director at ACHIEVE LIFE SCIENCES, INC..","evidence_excerpt":"the Board of Directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”) appointed Jeff Farrow and Reid Waldman, M.D. (together, the “Incoming Directors”), as directors, effective as of such date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526252624/0001193125-26-252624-index.htm","confidence":0.95}],"comparable_filings":[{"accession":"0001104659-26-069317","ticker":null,"company_name":"Cornerstone Building Brands, Inc.","filed_at":"2026-06-02T14:32:08+00:00","headline":"Cornerstone Building Brands names Richard Dirkson as Corporate Controller; CAO departs","event_type":"leadership","sec_items":["5.02","5.07"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069317","json":"https://secwatch.observer/filing/0001104659-26-069317.json","markdown":"https://secwatch.observer/filing/0001104659-26-069317.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/883902/000110465926069317/0001104659-26-069317-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883902/000110465926069317/tm2616548d1_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"the Board of Directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”) appointed Jeff Farrow and Reid Waldman, M.D. (together, the “Incoming Directors”), as directors, effective as of such date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526252624/0001193125-26-252624-index.htm","comparable_excerpt":"On May 27, 2026, the Company appointed Richard Dirkson as Senior Vice President, Corporate Controller (principal accounting officer) of the Company, effective May 28, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/883902/000110465926069317/0001104659-26-069317-index.htm"}},{"accession":"0001317685-26-000018","ticker":"ALH","company_name":"Alliance Laundry Holdings Inc.","filed_at":"2026-06-02T13:16:32+00:00","headline":"COO International Jan Vleugels to retire Sept 30; Bob Calver named successor; new VP IR","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001317685-26-000018","json":"https://secwatch.observer/filing/0001317685-26-000018.json","markdown":"https://secwatch.observer/filing/0001317685-26-000018.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1317685/000131768526000018/0001317685-26-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1317685/000131768526000018/all-20260602.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"the Board of Directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”) appointed Jeff Farrow and Reid Waldman, M.D. (together, the “Incoming Directors”), as directors, effective as of such date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526252624/0001193125-26-252624-index.htm","comparable_excerpt":"Mr. Jan Vleugals, Chief Operating Officer International of Alliance Laundry Holdings Inc. (the “Company”), provided notice of his decision to retire effective as of September 30, 2026","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1317685/000131768526000018/0001317685-26-000018-index.htm"}},{"accession":"0001129928-26-000039","ticker":"ONCY","company_name":"ONCOLYTICS BIOTECH INC","filed_at":"2026-06-02T13:02:48+00:00","headline":"Oncolytics appoints Steve Glover to board, promotes John McAdory to COO","event_type":"leadership","sec_items":["5.02","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001129928-26-000039","json":"https://secwatch.observer/filing/0001129928-26-000039.json","markdown":"https://secwatch.observer/filing/0001129928-26-000039.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1129928/000112992826000039/0001129928-26-000039-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1129928/000112992826000039/oncy-20260602.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"the Board of Directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”) appointed Jeff Farrow and Reid Waldman, M.D. (together, the “Incoming Directors”), as directors, effective as of such date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526252624/0001193125-26-252624-index.htm","comparable_excerpt":"appointed John McAdory as Chief Operating Officer of the Company","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1129928/000112992826000039/0001129928-26-000039-index.htm"}},{"accession":"0001568651-26-000048","ticker":"OSCR","company_name":"Oscar Health, Inc.","filed_at":"2026-06-02T10:31:58+00:00","headline":"Oscar Health Co-Founder Schlosser transitions from CTO to Advisor to CEO","event_type":"leadership","sec_items":["5.02"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001568651-26-000048","json":"https://secwatch.observer/filing/0001568651-26-000048.json","markdown":"https://secwatch.observer/filing/0001568651-26-000048.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1568651/000156865126000048/0001568651-26-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1568651/000156865126000048/oscr-20260529.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"the Board of Directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”) appointed Jeff Farrow and Reid Waldman, M.D. (together, the “Incoming Directors”), as directors, effective as of such date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526252624/0001193125-26-252624-index.htm","comparable_excerpt":"Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1568651/000156865126000048/0001568651-26-000048-index.htm"}},{"accession":"0001104659-26-069164","ticker":"PAGP","company_name":"PLAINS GP HOLDINGS LP","filed_at":"2026-06-02T10:05:30+00:00","headline":"Plains GP Holdings announces CAO succession: Montgomery promoted, Herbold retiring","event_type":"leadership","sec_items":["5.02"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069164","json":"https://secwatch.observer/filing/0001104659-26-069164.json","markdown":"https://secwatch.observer/filing/0001104659-26-069164.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1581990/000110465926069164/0001104659-26-069164-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1581990/000110465926069164/tm2614304d4_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"the Board of Directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”) appointed Jeff Farrow and Reid Waldman, M.D. (together, the “Incoming Directors”), as directors, effective as of such date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526252624/0001193125-26-252624-index.htm","comparable_excerpt":"effective September 1, 2026, Russ Montgomery will be promoted to the position of Vice President, Accounting and Chief Accounting Officer of Plains All American GP LLC, the general partner of PAA, and PAA GP Holdings LLC, the general partner of PAGP.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1581990/000110465926069164/0001104659-26-069164-index.htm"}},{"accession":"0001104659-26-069156","ticker":"PAA","company_name":"PLAINS ALL AMERICAN PIPELINE LP","filed_at":"2026-06-02T10:03:41+00:00","headline":"Plains All American announces CAO retirement and Montgomery promotion effective Sep 1, 2026","event_type":"leadership","sec_items":["5.02"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069156","json":"https://secwatch.observer/filing/0001104659-26-069156.json","markdown":"https://secwatch.observer/filing/0001104659-26-069156.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1070423/000110465926069156/0001104659-26-069156-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1070423/000110465926069156/tm2615397d2_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"the Board of Directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”) appointed Jeff Farrow and Reid Waldman, M.D. (together, the “Incoming Directors”), as directors, effective as of such date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526252624/0001193125-26-252624-index.htm","comparable_excerpt":"Chris Herbold, who previously served as Senior Vice President, Finance and Chief Accounting Officer of PAA and PAGP, is retiring from the company on August 31, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1070423/000110465926069156/0001104659-26-069156-index.htm"}},{"accession":"0001104659-26-069119","ticker":"AHCO","company_name":"AdaptHealth Corp.","filed_at":"2026-06-02T01:02:57+00:00","headline":"AdaptHealth amends 8-K to disclose COO Daniel McFadden's compensation: base salary raised to $550K, plus RSU grant","event_type":"leadership","sec_items":["5.02","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069119","json":"https://secwatch.observer/filing/0001104659-26-069119.json","markdown":"https://secwatch.observer/filing/0001104659-26-069119.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725255/000110465926069119/0001104659-26-069119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725255/000110465926069119/tm2616604d1_8ka.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"the Board of Directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”) appointed Jeff Farrow and Reid Waldman, M.D. (together, the “Incoming Directors”), as directors, effective as of such date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526252624/0001193125-26-252624-index.htm","comparable_excerpt":"the appointment of Daniel McFadden as Chief Operating Officer of the Company, effective as of May 4, 2026","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1725255/000110465926069119/0001104659-26-069119-index.htm"}},{"accession":"0000773840-26-000068","ticker":"HON","company_name":"HONEYWELL INTERNATIONAL INC","filed_at":"2026-06-02T00:12:40+00:00","headline":"Honeywell appoints Jill Evanko to Board of Directors, effective June 1, 2026","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000773840-26-000068","json":"https://secwatch.observer/filing/0000773840-26-000068.json","markdown":"https://secwatch.observer/filing/0000773840-26-000068.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/773840/000077384026000068/0000773840-26-000068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/773840/000077384026000068/hon-20260601.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"the Board of Directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”) appointed Jeff Farrow and Reid Waldman, M.D. (together, the “Incoming Directors”), as directors, effective as of such date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526252624/0001193125-26-252624-index.htm","comparable_excerpt":"Ms. Jillian Evanko, 48, Chief Executive Officer of Duravant LLC, has been appointed to serve as an Independent Director on the Company’s Board of Directors and a member of the Audit Committee, in each case, effective June 1, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/773840/000077384026000068/0000773840-26-000068-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}